Randolph Alan Chen, MD
Internal Medicine · Burlingame
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 14
- 4 carriers
- Offices
- 3
- Since medical school
- 27 years
- Wake Forest University School of Medicine, 1999
Offices
3 locations · San Mateo Dialysis Associates · County of San Mateo
Hospitals listed: 052793 · 052819 · 552733 · Mills-Peninsula Medical Center · San Mateo Medical Center. That is not proof they admit you there this week.
Plans that list them
14 plans · 4 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chen’s office at (650) 692-6302 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
14 of 14 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Anthem Full Dual Advantage Aligned (HMO D-SNP) | Anthem Blue Cross | Listed | Oct 3, 2026 |
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A37526 · Cancelled
Licence status: Cancelled · since 1981 · University of California, Davis School of Medicine.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Peninsula Medical CenterBurlingame, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.139, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.242, Oct 2024 – Sep 2025
- San Mateo Medical CenterSan Mateo, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of San Mateo County HealthPatients rate it 3 of 5 · 68% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for Peninsula Medical Center
Behind the star rating — Deaths: 2 better, 6 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.139 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.242 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.21 (0.27 to 2.15) · 1,258 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.81 (0.51 to 1.1) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 155.44 (112.67 to 198.21) · 90 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.5 · 32 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.1 · 82 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10 · 188 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9 · 473 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.8 · 342 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.4 · 485 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.9 · 3,730 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.4) · 6,904 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,052 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.41 (1.43 to 5.39) · 1,695 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.72 (0.17 to 3.28) · 665 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.11 (0.66 to 3.56) · 1,545 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.1 (1.3 to 12.9) · 670 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.96 (2.63 to 9.29) · 653 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.61 (0.15 to 3.08) · 418 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 5,539 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 192 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.215 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.263 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.74 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 300 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19 · 702 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 1.2 · 207 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -13.6 · 531 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 24.3 · 343 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.1 · 449 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.5 (2.8 to 7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.6 (6.7 to 13.7) · 85 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.7 · 189 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 45 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.6 · 117 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.7 to 17.2) · 584 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.2) · 764 cases | No different | Jan 2024 – Dec 2024 |
What patients said (523 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 58% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 79% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 79% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 54% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for San Mateo Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.34 (0.25 to 2.43) · 45 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.48 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 25 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 258 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 379 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (0.82 to 6.05) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (0.92 to 4.37) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.76) · 296 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.661 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 47 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.3 · 25 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 18.9) · 167 cases | No different | Jan 2022 – Dec 2024 |
What patients said (208 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$181,812
Medicare paid this office $181,812 for 380 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Dialysis services, 4 or more physician visits per month (20 years or older) | 31 | $74,532 | $314 |
| Return visit (30+ min) | 283 | $44,862 | $74 |
| New patient visit (60+ min) | 100 | $19,079 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $12,494 | $103 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 12 | $7,792 | $260 |
See all 6 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 31 | $74,532 | $314 |
| Return visit (30+ min) | 283 | $44,862 | $74 |
| New patient visit (60+ min) | 100 | $19,079 | $191 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 38 | $12,494 | $103 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 12 | $7,792 | $260 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,830 | $153 |
Who their Medicare patients are
380 Original Medicare patients in 2024. Average age 78 · Under 65 5% · 85 and older 25% · Women 45% · Also on Medicaid 14% · Health risk score 2.50. Above the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Chronic kidney disease 75% · Diabetes 52% · Coronary heart disease 38% · Heart failure 34% · Atrial fibrillation 28% · Cancer 17% · Depression 16% · COPD 13% · Stroke 10% · Dementia 9%.
The office billed $363,009, Medicare allowed $244,737 and paid $181,812; for 1,205 services of 12 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 380 | 1,205 | 78 | 2.50 | $363,009 | $181,812 |
| 2023 | 344 | 1,172 | 77 | 3.04 | $366,584 | $208,470 |
| 2022 | 330 | 1,152 | 77 | 2.86 | $350,154 | $196,902 |
| 2021 | 326 | 1,103 | 77 | 2.82 | $343,278 | $201,015 |
| 2020 | 300 | 679 | 76 | 2.60 | $146,080 | $79,884 |
| 2019 | 283 | 793 | 77 | 2.01 | $156,404 | $83,502 |
| 2018 | 328 | 1,033 | 76 | 2.34 | $204,511 | $109,552 |
| 2017 | 307 | 1,021 | 77 | 2.63 | $203,731 | $109,361 |
| 2016 | 250 | 858 | 78 | 1.99 | $169,195 | $90,514 |
| 2015 | 243 | 999 | 77 | 2.27 | $193,430 | $105,628 |
| 2014 | 207 | 871 | 77 | 2.35 | $158,424 | $90,550 |
| 2013 | 207 | 890 | 75 | 2.82 | $168,097 | $88,468 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 31 | $83,348 | $312 |
| Return visit (30+ min) | 232 | $59,249 | $115 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 56 | $16,751 | $107 |
| New patient visit (60+ min) | 72 | $14,361 | $199 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 13 | $6,861 | $264 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,285 | $155 |
2022: 6 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 29 | $81,378 | $315 |
| Return visit (30+ min) | 230 | $62,260 | $111 |
| New patient visit (60+ min) | 56 | $11,211 | $200 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 48 | $10,562 | $90 |
| Dialysis services, 2-3 physician visits per month (20 years or older) | 16 | $7,286 | $260 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 22 | $4,052 | $176 |
2021: 5 services
| Dialysis services, 4 or more physician visits per month (20 years or older) | 34 | $84,933 | $322 |
| Return visit (30+ min) | 225 | $56,759 | $115 |
| New patient visit (60+ min) | 73 | $14,185 | $194 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 40 | $10,527 | $92 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 19 | $3,759 | $179 |
2020: 6 services
| Return visit (30+ min) | 199 | $41,823 | $99 |
| New patient visit (60+ min) | 70 | $12,784 | $183 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 47 | $10,140 | $95 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 29 | $5,372 | $185 |
| Dialysis services, 4 or more physician visits per month (20 years or older) | 18 | $5,094 | $268 |
| Telephone medical discussion with physician, 21-30 minutes | 12 | $1,367 | $105 |
2019: 4 services
| Return visit (30+ min) | 211 | $45,027 | $95 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 61 | $20,115 | $94 |
| New patient visit (60+ min) | 59 | $10,971 | $186 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $6,551 | $182 |
2018: 4 services
| Return visit (30+ min) | 204 | $44,429 | $94 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 93 | $35,646 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $14,208 | $180 |
| New patient visit (60+ min) | 72 | $13,422 | $186 |
2017: 5 services
| Return visit (30+ min) | 167 | $39,674 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 100 | $38,100 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 72 | $14,198 | $180 |
| New patient visit (60+ min) | 76 | $14,138 | $186 |
| Return visit (30+ min) | 12 | $943 | $67 |
2016: 4 services
| Return visit (30+ min) | 172 | $37,221 | $92 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 73 | $28,145 | $91 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 61 | $12,551 | $177 |
| New patient visit (60+ min) | 63 | $11,720 | $186 |
2015: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 95 | $40,365 | $92 |
| Return visit (30+ min) | 140 | $31,947 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 83 | $17,305 | $178 |
| New patient visit (60+ min) | 56 | $10,437 | $186 |
2014: 4 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 70 | $33,670 | $93 |
| Return visit (30+ min) | 115 | $28,278 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 63 | $12,782 | $180 |
| New patient visit (60+ min) | 46 | $8,553 | $186 |
2013: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 79 | $34,781 | $89 |
| Return visit (30+ min) | 97 | $22,392 | $93 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 78 | $15,744 | $173 |
| New patient visit (60+ min) | 30 | $5,289 | $176 |
| Return visit (30+ min) | 11 | $1,169 | $65 |
Medicaid work
$98,482 in 2024
Medicaid paid $98,482 for 416 billed services this clinician did in 2024, up to 41 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 372 | $94,124 |
| Return visit (30+ min) | 44 | $4,358 |
| 2024 | 416 | 2 | 41 | $98,482 |
| 2023 | 507 | 2 | 43 | $119,079 |
| 2022 | 522 | 2 | 47 | $133,357 |
| 2021 | 478 | 1 | 46 | $115,060 |
| 2020 | 38 | 1 | 38 | $8,785 |
| 2019 | 12 | 1 | 12 | $116 |
See the largest Medicaid services in earlier years
2023
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 474 | $118,268 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 33 | $810 |
2022
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 504 | $128,963 |
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 2-3 face-to-face visits by a physician or other qualified health care professional per month | 18 | $4,394 |
2021
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 478 | $115,060 |
2020
| End-stage renal disease (ESRD) related services monthly, for patients 20 years of age and older; with 4 or more face-to-face visits by a physician or other qualified health care professional per month | 38 | $8,785 |
2019
| Return visit (30+ min) | 12 | $116 |
Drugs they prescribed that Part D paid
$290,386
Pharmacies billed $290,386 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,241) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
2,003 generic and 238 brand-name prescriptions · $290,386 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Farxiga | 66 | $64,785 | $982 |
| Jardiance | 58 | $59,637 | $1,028 |
| Veltassa | 25 | $32,656 | $1,306 |
| Kerendia | 26 | $20,479 | $788 |
| Cinacalcet | 42 | $15,661 | $373 |
See all 35 drugs
| Farxiga | 66 | $64,785 | $982 |
| Jardiance | 58 | $59,637 | $1,028 |
| Veltassa | 25 | $32,656 | $1,306 |
| Kerendia | 26 | $20,479 | $788 |
| Cinacalcet | 42 | $15,661 | $373 |
| Sevelamer Carbonate | 50 | $15,386 | $308 |
| Lokelma | 15 | $11,761 | $784 |
| Retacrit | 29 | $5,983 | $206 |
| Losartan | 391 | $5,491 | $14 |
| Potassium Citrate Er | 14 | $3,675 | $262 |
| Metoprolol | 192 | $3,153 | $16 |
| Doxazosin Mesylate | 150 | $2,761 | $18 |
| Calcitriol | 112 | $2,396 | $21 |
| Potassium Chloride | 16 | $2,268 | $142 |
| Chlorthalidone | 88 | $2,202 | $25 |
| Amlodipine Besylate | 199 | $1,772 | $9 |
| Hydralazine | 52 | $1,693 | $33 |
| Valsartan | 35 | $1,264 | $36 |
| Allopurinol | 64 | $1,220 | $19 |
| Calcium Acetate | 19 | $1,214 | $64 |
| Eplerenone | 11 | $1,117 | $102 |
| Irbesartan | 27 | $994 | $37 |
| Mycophenolic Acid | 13 | $957 | $74 |
| Bisoprolol | 21 | $799 | $38 |
| Hydrochlorothiazide | 94 | $694 | $7 |
| Torsemide | 20 | $618 | $31 |
| Labetalol | 12 | $571 | $48 |
| Bumetanide | 12 | $567 | $47 |
| Tamsulosin | 24 | $534 | $22 |
| Sodium Polystyrene Sulfonate | 11 | $510 | $46 |
| Furosemide | 72 | $502 | $7 |
| Lisinopril | 50 | $409 | $8 |
| Benazepril | 13 | $315 | $24 |
| Spironolactone | 32 | $286 | $9 |
| Carvedilol | 20 | $200 | $10 |
Year by year
| 2024 | 2,241 | 378 | 0% (0) | 11% | $290,386 |
| 2023 | 2,098 | 352 | 0% (0) | 8% | $213,002 |
| 2022 | 1,937 | 321 | 0% (0) | 9% | $143,329 |
| 2021 | 1,886 | 316 | 0% (0) | 9% | $171,144 |
| 2020 | 1,948 | 298 | 0% (0) | None | $187,593 |
| 2019 | 1,834 | 284 | 0% (0) | 13% | $216,093 |
| 2018 | 1,943 | 291 | 0% (0) | None | $258,077 |
| 2017 | 2,146 | 268 | None | 20% | $455,261 |
| 2016 | 2,266 | 234 | None | None | $399,097 |
| 2015 | 1,935 | 197 | None | None | $296,368 |
| 2014 | 1,857 | 175 | 1% (24) | None | $256,708 |
| 2013 | 1,649 | 163 | 2% (25) | None | $205,090 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 34 drugs
| Veltassa | 31 | $40,077 | $1,293 |
| Farxiga | 22 | $25,038 | $1,138 |
| Jardiance | 21 | $17,086 | $814 |
| Kerendia | 21 | $15,527 | $739 |
| Sevelamer Carbonate | 39 | $11,399 | $292 |
| Cinacalcet | 43 | $10,964 | $255 |
| Losartan | 320 | $5,672 | $18 |
| Prosol | 34 | $5,324 | $157 |
| Metoprolol | 166 | $4,301 | $26 |
| Doxazosin Mesylate | 166 | $4,158 | $25 |
| Allopurinol | 64 | $4,134 | $65 |
| Potassium Chloride | 17 | $3,530 | $208 |
| Labetalol | 20 | $3,519 | $176 |
| Amlodipine Besylate | 215 | $3,276 | $15 |
| Calcitriol | 118 | $2,813 | $24 |
| Chlorthalidone | 90 | $2,720 | $30 |
| Calcium Acetate | 19 | $2,468 | $130 |
| Potassium Citrate Er | 14 | $2,365 | $169 |
| Hydralazine | 68 | $2,000 | $29 |
| Valsartan | 28 | $1,319 | $47 |
| Irbesartan | 27 | $1,317 | $49 |
| Torsemide | 17 | $877 | $52 |
| Furosemide | 106 | $857 | $8 |
| Mycophenolic Acid | 11 | $810 | $74 |
| Bisoprolol | 15 | $584 | $39 |
| Terazosin | 14 | $529 | $38 |
| Hydrochlorothiazide | 71 | $510 | $7 |
| Tamsulosin | 20 | $495 | $25 |
| Lisinopril | 53 | $471 | $9 |
| Carvedilol | 15 | $419 | $28 |
| Spironolactone | 32 | $272 | $8 |
| Benazepril | 16 | $233 | $15 |
| Metoprolol | 11 | $212 | $19 |
| Prednisone | 14 | $103 | $7 |
2022: 32 drugs
| Veltassa | 31 | $38,869 | $1,254 |
| Cinacalcet | 48 | $13,690 | $285 |
| Lanthanum Carbonate | 12 | $8,637 | $720 |
| Sevelamer Carbonate | 30 | $8,074 | $269 |
| Prosol | 40 | $5,327 | $133 |
| Metoprolol | 154 | $4,503 | $29 |
| Losartan | 304 | $4,470 | $15 |
| Potassium Chloride | 35 | $3,787 | $108 |
| Calcitriol | 123 | $3,336 | $27 |
| Chlorthalidone | 75 | $3,011 | $40 |
| Clonidine | 13 | $2,593 | $199 |
| Doxazosin Mesylate | 108 | $2,411 | $22 |
| Amlodipine Besylate | 214 | $2,220 | $10 |
| Calcium Acetate | 21 | $2,076 | $99 |
| Hydralazine | 54 | $1,997 | $37 |
| Irbesartan | 23 | $1,343 | $58 |
| Furosemide | 127 | $1,311 | $10 |
| Valsartan | 20 | $1,209 | $60 |
| Bumetanide | 12 | $1,133 | $94 |
| Allopurinol | 66 | $1,110 | $17 |
| Torsemide | 11 | $1,091 | $99 |
| Mycophenolic Acid | 13 | $958 | $74 |
| Bisoprolol | 23 | $889 | $39 |
| Tamsulosin | 21 | $578 | $28 |
| Lisinopril | 46 | $534 | $12 |
| Terazosin | 14 | $397 | $28 |
| Hydrochlorothiazide | 42 | $292 | $7 |
| Metoprolol | 15 | $224 | $15 |
| Prednisone | 26 | $203 | $8 |
| Spironolactone | 19 | $203 | $11 |
| Omeprazole | 17 | $193 | $11 |
| Gabapentin | 11 | $130 | $12 |
2021: 31 drugs
| Veltassa | 28 | $35,199 | $1,257 |
| Auryxia | 13 | $20,963 | $1,613 |
| Cinacalcet | 51 | $20,443 | $401 |
| Lanthanum Carbonate | 28 | $17,550 | $627 |
| Sevelamer Carbonate | 35 | $8,643 | $247 |
| Calcitriol | 178 | $6,806 | $38 |
| Clinisol | 35 | $5,961 | $170 |
| Retacrit | 13 | $5,794 | $446 |
| Metoprolol | 135 | $4,856 | $36 |
| Losartan | 271 | $4,274 | $16 |
| Chlorthalidone | 66 | $2,870 | $43 |
| Labetalol | 19 | $2,619 | $138 |
| Potassium Chloride | 19 | $2,293 | $121 |
| Bumetanide | 12 | $2,175 | $181 |
| Amlodipine Besylate | 204 | $2,092 | $10 |
| Doxazosin Mesylate | 82 | $1,945 | $24 |
| Hydralazine | 54 | $1,798 | $33 |
| Bisoprolol | 27 | $1,309 | $48 |
| Furosemide | 132 | $1,264 | $10 |
| Mycophenolic Acid | 13 | $1,089 | $84 |
| Irbesartan | 17 | $1,009 | $59 |
| Allopurinol | 35 | $925 | $26 |
| Lisinopril | 58 | $799 | $14 |
| Valsartan | 13 | $588 | $45 |
| Tamsulosin | 24 | $330 | $14 |
| Spironolactone | 32 | $304 | $9 |
| Terazosin | 11 | $273 | $25 |
| Omeprazole | 19 | $262 | $14 |
| Prednisone | 29 | $224 | $8 |
| Hydrochlorothiazide | 41 | $185 | $5 |
| Atorvastatin | 11 | $133 | $12 |
2020: 32 drugs
| Cinacalcet | 53 | $54,333 | $1,025 |
| Veltassa | 25 | $22,119 | $885 |
| Lanthanum Carbonate | 20 | $12,489 | $624 |
| Sevelamer Carbonate | 37 | $11,738 | $317 |
| Clinisol | 73 | $10,580 | $145 |
| Calcitriol | 240 | $9,586 | $40 |
| Metoprolol | 131 | $4,461 | $34 |
| Potassium Chloride | 35 | $3,557 | $102 |
| Labetalol | 22 | $3,018 | $137 |
| Bumetanide | 13 | $2,901 | $223 |
| Losartan | 213 | $2,856 | $13 |
| Chlorthalidone | 55 | $2,800 | $51 |
| Doxazosin Mesylate | 59 | $2,028 | $34 |
| Hydralazine | 56 | $1,734 | $31 |
| Amlodipine Besylate | 186 | $1,547 | $8 |
| Furosemide | 144 | $1,289 | $9 |
| Bisoprolol | 26 | $1,242 | $48 |
| Irbesartan | 18 | $1,110 | $62 |
| Mycophenolate Mofetil | 17 | $1,059 | $62 |
| Calcium Acetate | 11 | $1,022 | $93 |
| Allopurinol | 47 | $967 | $21 |
| Tamsulosin | 33 | $654 | $20 |
| Lisinopril | 56 | $622 | $11 |
| Spironolactone | 35 | $602 | $17 |
| Omeprazole | 21 | $381 | $18 |
| Hydrochlorothiazide | 44 | $320 | $7 |
| Prednisone | 34 | $291 | $9 |
| Carvedilol | 17 | $288 | $17 |
| Atorvastatin | 16 | $234 | $15 |
| Tacrolimus | 12 | $233 | $19 |
| Minoxidil | 15 | $213 | $14 |
| Gabapentin | 12 | $166 | $14 |
2019: 36 drugs
| Cinacalcet | 24 | $42,423 | $1,768 |
| Veltassa | 34 | $28,990 | $853 |
| Sensipar | 28 | $28,149 | $1,005 |
| Sevelamer Carbonate | 34 | $24,590 | $723 |
| Renvela | 14 | $13,093 | $935 |
| Calcitriol | 237 | $10,763 | $45 |
| Lanthanum Carbonate | 12 | $8,187 | $682 |
| Clinisol | 37 | $5,697 | $154 |
| Potassium Chloride | 31 | $3,757 | $121 |
| Labetalol | 30 | $3,172 | $106 |
| Chlorthalidone | 61 | $3,100 | $51 |
| Cyclosporine Modified | 12 | $2,727 | $227 |
| Potassium Citrate Er | 12 | $2,520 | $210 |
| Metoprolol | 80 | $2,397 | $30 |
| Amlodipine Besylate | 193 | $2,253 | $12 |
| Irbesartan | 51 | $2,239 | $44 |
| Hydralazine | 68 | $1,994 | $29 |
| Losartan | 136 | $1,629 | $12 |
| Bumetanide | 12 | $1,589 | $132 |
| Bisoprolol | 25 | $1,511 | $60 |
| Furosemide | 155 | $1,442 | $9 |
| Doxazosin Mesylate | 33 | $1,267 | $38 |
| Tamsulosin | 38 | $866 | $23 |
| Allopurinol | 39 | $755 | $19 |
| Lisinopril | 51 | $628 | $12 |
| Prednisone | 37 | $539 | $15 |
| Gabapentin | 22 | $533 | $24 |
| Atorvastatin | 21 | $494 | $24 |
| Spironolactone | 22 | $425 | $19 |
| Mycophenolate Mofetil | 12 | $371 | $31 |
| Pantoprazole | 13 | $369 | $28 |
| Minoxidil | 13 | $230 | $18 |
| Carvedilol | 12 | $199 | $17 |
| Hydrochlorothiazide | 35 | $196 | $6 |
| Omeprazole | 18 | $187 | $10 |
| Levothyroxine | 12 | $116 | $10 |
2018: 34 drugs
| Sensipar | 41 | $69,636 | $1,698 |
| Sevelamer Carbonate | 29 | $35,731 | $1,232 |
| Renvela | 18 | $34,451 | $1,914 |
| Veltassa | 34 | $28,614 | $842 |
| Renagel | 11 | $11,589 | $1,054 |
| Calcitriol | 239 | $10,917 | $46 |
| Potassium Chloride | 42 | $4,576 | $109 |
| Clinisol | 24 | $3,537 | $147 |
| Chlorthalidone | 60 | $3,533 | $59 |
| Metoprolol | 75 | $3,255 | $43 |
| Labetalol | 42 | $2,294 | $55 |
| Losartan | 188 | $2,147 | $11 |
| Amlodipine Besylate | 194 | $1,952 | $10 |
| Hydralazine | 49 | $1,194 | $24 |
| Valsartan | 20 | $1,180 | $59 |
| Irbesartan | 40 | $1,169 | $29 |
| Tamsulosin | 43 | $1,134 | $26 |
| Furosemide | 155 | $1,113 | $7 |
| Lidocaine-Prilocaine | 16 | $1,075 | $67 |
| Doxazosin Mesylate | 25 | $1,041 | $42 |
| Atorvastatin | 34 | $950 | $28 |
| Bisoprolol | 25 | $932 | $37 |
| Travasol | 14 | $927 | $66 |
| Allopurinol | 43 | $726 | $17 |
| Lisinopril | 56 | $431 | $8 |
| Spironolactone | 21 | $363 | $17 |
| Prednisone | 22 | $330 | $15 |
| Carvedilol | 33 | $328 | $10 |
| Omeprazole | 15 | $315 | $21 |
| Minoxidil | 14 | $261 | $19 |
| Hydrochlorothiazide | 29 | $172 | $6 |
| Pantoprazole | 12 | $169 | $14 |
| Gabapentin | 18 | $111 | $6 |
| Metoprolol | 20 | $109 | $5 |
2017: 38 drugs
| Sensipar | 144 | $228,304 | $1,585 |
| Renvela | 46 | $78,466 | $1,706 |
| Renagel | 19 | $39,632 | $2,086 |
| Clinisol | 170 | $25,065 | $147 |
| Procrit | 15 | $11,433 | $762 |
| Calcitriol | 292 | $9,348 | $32 |
| Metoprolol | 99 | $2,765 | $28 |
| Lamotrigine | 12 | $1,608 | $134 |
| Tamsulosin | 87 | $1,469 | $17 |
| Amlodipine Besylate | 125 | $1,327 | $11 |
| Hydralazine | 70 | $1,264 | $18 |
| Potassium Chloride | 11 | $1,219 | $111 |
| Valsartan | 19 | $1,213 | $64 |
| Losartan | 137 | $1,147 | $8 |
| Travasol | 15 | $1,067 | $71 |
| Chlorthalidone | 26 | $1,039 | $40 |
| Labetalol | 15 | $960 | $64 |
| Atorvastatin | 28 | $672 | $24 |
| Lidocaine-Prilocaine | 13 | $670 | $52 |
| Furosemide | 133 | $666 | $5 |
| Minoxidil | 24 | $552 | $23 |
| Doxazosin Mesylate | 15 | $508 | $34 |
| Allopurinol | 28 | $504 | $18 |
| Torsemide | 15 | $499 | $33 |
| Omeprazole | 28 | $396 | $14 |
| Lisinopril | 93 | $395 | $4 |
| Carvedilol | 38 | $353 | $9 |
| Spironolactone | 28 | $347 | $12 |
| Fenofibrate | 12 | $345 | $29 |
| Calcium Acetate | 12 | $340 | $28 |
| Hydrochlorothiazide | 61 | $284 | $5 |
| Pantoprazole | 25 | $267 | $11 |
| Gabapentin | 19 | $164 | $9 |
| Escitalopram | 11 | $139 | $13 |
| Alendronate | 11 | $69 | $6 |
| Metoprolol | 12 | $68 | $6 |
| Cephalexin | 11 | $47 | $4 |
| Simvastatin | 11 | $35 | $3 |
2016: 42 drugs
| Sensipar | 129 | $153,824 | $1,192 |
| Renvela | 58 | $121,077 | $2,088 |
| Clinisol | 164 | $22,798 | $139 |
| Procrit | 33 | $22,603 | $685 |
| Renagel | 13 | $22,379 | $1,721 |
| Calcitriol | 312 | $6,990 | $22 |
| Toviaz | 12 | $3,214 | $268 |
| Flovent Hfa | 13 | $2,862 | $220 |
| Metoprolol | 97 | $2,475 | $26 |
| Potassium Chloride | 13 | $2,191 | $169 |
| Tamsulosin | 83 | $1,802 | $22 |
| Clonidine | 11 | $1,230 | $112 |
| Hydrocortisone | 13 | $1,132 | $87 |
| Amlodipine Besylate | 143 | $1,052 | $7 |
| Spironolactone | 56 | $999 | $18 |
| Metolazone | 17 | $982 | $58 |
| Potassium Citrate Er | 14 | $915 | $65 |
| Hydralazine | 53 | $868 | $16 |
| Chlorthalidone | 22 | $860 | $39 |
| Torsemide | 28 | $794 | $28 |
| Allopurinol | 52 | $792 | $15 |
| Losartan | 107 | $716 | $7 |
| Lisinopril | 134 | $609 | $5 |
| Atorvastatin | 23 | $607 | $26 |
| Furosemide | 116 | $510 | $4 |
| Amlodipine Besylate-Benazepril | 12 | $453 | $38 |
| Valsartan | 16 | $443 | $28 |
| Fenofibrate | 11 | $406 | $37 |
| Doxazosin Mesylate | 16 | $339 | $21 |
| Pantoprazole | 30 | $230 | $8 |
| Minoxidil | 12 | $225 | $19 |
| Escitalopram | 14 | $206 | $15 |
| Hydrochlorothiazide | 62 | $203 | $3 |
| Carvedilol | 35 | $199 | $6 |
| Levothyroxine | 14 | $195 | $14 |
| Simvastatin | 16 | $176 | $11 |
| Metoprolol | 22 | $147 | $7 |
| Bisoprolol | 11 | $145 | $13 |
| Omeprazole | 22 | $135 | $6 |
| Gabapentin | 14 | $111 | $8 |
| Prednisone | 12 | $93 | $8 |
| Cephalexin | 11 | $77 | $7 |
2015: 33 drugs
| Sensipar | 96 | $88,715 | $924 |
| Renvela | 46 | $75,513 | $1,642 |
| Renagel | 30 | $47,568 | $1,586 |
| Clinisol | 166 | $19,535 | $118 |
| Calcitriol | 151 | $3,125 | $21 |
| Metoprolol | 102 | $2,831 | $28 |
| Toviaz | 11 | $2,541 | $231 |
| Tamsulosin | 69 | $1,389 | $20 |
| Clonidine | 12 | $1,370 | $114 |
| Lisinopril | 156 | $779 | $5 |
| Amlodipine Besylate | 150 | $750 | $5 |
| Proair Hfa | 14 | $742 | $53 |
| Losartan | 90 | $728 | $8 |
| Hydralazine | 34 | $714 | $21 |
| Spironolactone | 31 | $689 | $22 |
| Valsartan | 12 | $586 | $49 |
| Doxazosin Mesylate | 26 | $554 | $21 |
| Furosemide | 127 | $553 | $4 |
| Labetalol | 13 | $520 | $40 |
| Fenofibrate | 12 | $442 | $37 |
| Simvastatin | 28 | $374 | $13 |
| Allopurinol | 27 | $337 | $12 |
| Atorvastatin | 23 | $284 | $12 |
| Metoprolol | 33 | $228 | $7 |
| Escitalopram | 19 | $226 | $12 |
| Fludrocortisone Acetate | 13 | $214 | $16 |
| Hydrochlorothiazide | 40 | $208 | $5 |
| Levothyroxine | 13 | $164 | $13 |
| Pantoprazole | 16 | $119 | $7 |
| Bisoprolol | 15 | $113 | $8 |
| Omeprazole | 12 | $110 | $9 |
| Gabapentin | 16 | $104 | $6 |
| Prednisone | 22 | $86 | $4 |
2014: 33 drugs
| Renvela | 64 | $83,950 | $1,312 |
| Renagel | 51 | $56,455 | $1,107 |
| Sensipar | 38 | $33,389 | $879 |
| Clinisol | 207 | $24,198 | $117 |
| Metoprolol | 96 | $2,837 | $30 |
| Toviaz | 11 | $2,142 | $195 |
| Calcitriol | 96 | $2,099 | $22 |
| Hydralazine | 85 | $1,933 | $23 |
| Losartan | 100 | $1,193 | $12 |
| Calcium Acetate | 19 | $1,020 | $54 |
| Tamsulosin | 54 | $992 | $18 |
| Labetalol | 17 | $709 | $42 |
| Lisinopril | 125 | $656 | $5 |
| Amlodipine Besylate | 105 | $620 | $6 |
| Doxazosin Mesylate | 29 | $619 | $21 |
| Furosemide | 130 | $610 | $5 |
| Proair Hfa | 12 | $601 | $50 |
| Hydrocodone-Acetaminophen | 22 | $559 | $25 |
| Ondansetron Odt | 11 | $539 | $49 |
| Simvastatin | 38 | $521 | $14 |
| Fenofibrate | 11 | $455 | $41 |
| Pravastatin | 12 | $407 | $34 |
| Metoprolol | 64 | $377 | $6 |
| Spironolactone | 31 | $375 | $12 |
| Omeprazole | 21 | $283 | $13 |
| Atorvastatin | 19 | $277 | $15 |
| Gabapentin | 24 | $236 | $10 |
| Bisoprolol | 14 | $162 | $12 |
| Fludrocortisone Acetate | 11 | $153 | $14 |
| Levothyroxine | 11 | $142 | $13 |
| Carvedilol | 13 | $133 | $10 |
| Allopurinol | 11 | $105 | $10 |
| Hydrochlorothiazide | 30 | $66 | $2 |
2013: 32 drugs
| Renvela | 87 | $72,911 | $838 |
| Renagel | 58 | $40,416 | $697 |
| Sensipar | 35 | $24,591 | $703 |
| Clinisol | 179 | $22,653 | $127 |
| Procrit | 12 | $5,465 | $455 |
| Calcitriol | 90 | $2,563 | $28 |
| Metoprolol | 54 | $2,008 | $37 |
| Colcrys | 11 | $1,974 | $179 |
| Flovent Hfa | 11 | $1,865 | $170 |
| Nifedipine Er | 15 | $1,412 | $94 |
| Losartan | 85 | $1,296 | $15 |
| Hydralazine | 36 | $1,059 | $29 |
| Proair Hfa | 20 | $938 | $47 |
| Calcium Acetate | 16 | $893 | $56 |
| Tamsulosin | 45 | $720 | $16 |
| Atorvastatin | 22 | $692 | $31 |
| Furosemide | 125 | $687 | $5 |
| Lisinopril | 117 | $661 | $6 |
| Amlodipine Besylate | 86 | $607 | $7 |
| Omeprazole | 44 | $572 | $13 |
| Simvastatin | 48 | $470 | $10 |
| Metoprolol | 64 | $434 | $7 |
| Fenofibrate | 11 | $431 | $39 |
| Gabapentin | 23 | $301 | $13 |
| Carvedilol | 11 | $278 | $25 |
| Lidocaine-Prilocaine | 12 | $263 | $22 |
| Hydrocodone-Acetaminophen | 23 | $191 | $8 |
| Allopurinol | 24 | $186 | $8 |
| Cephalexin | 19 | $124 | $7 |
| Spironolactone | 16 | $120 | $7 |
| Levothyroxine | 12 | $89 | $7 |
| Hydrochlorothiazide | 11 | $21 | $2 |
Money from drug and device companies
$1,135 in 2025
| 2025 | 9 | 31 | None | $1,135 |
| 2024 | 10 | 47 | $2,400 | $5,593 |
| 2023 | 9 | 36 | $2,100 | $3,003 |
| 2022 | 6 | 42 | None | $1,208 |
| 2021 | 3 | 19 | None | $318 |
| 2020 | 1 | 1 | None | $107 |
| 2019 | 4 | 59 | None | $728 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| AstraZeneca Pharmaceuticals LP | Farxiga | $557 | 15 payments
|
| Novo Nordisk | Ozempic | $139 | 2 payments
|
| NxStage Medical | Nxstage System One | $131 | 1 payment
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $115 | 5 payments
|
| Amgen | Krystexxa | $58 | 2 payments
|
| Calliditas Therapeutics US | Tarpeyo | $43 | 1 payment
|
See all 29 published payments
| AstraZeneca Pharmaceuticals LP | Meals · 2025-12-13 | Farxiga | $29 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-11-21 | Kerendia | $17 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-11-08 | Farxiga | $29 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-10-11 | Kerendia | $30 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-10-04 | Lokelma | $24 |
| Novo Nordisk | Meals · 2025-09-16 | Ozempic | $110 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-09-11 | Lokelma | $32 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-09 | Lokelma | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-08 | None | $113 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-08-06 | Farxiga | $27 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-07-18 | Kerendia | $23 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-07-12 | Farxiga | $28 |
| Calliditas Therapeutics US | Meals · 2025-06-20 | Tarpeyo | $43 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-14 | Lokelma | $31 |
| Lilly USA | Meals · 2025-06-05 | Jardiance | $33 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-05-24 | Lokelma | $25 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-05-09 | Kerendia | $24 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-04-08 | Lokelma | $28 |
| Novo Nordisk | Meals · 2025-04-04 | None | $29 |
| Bayer Healthcare Pharmaceuticals | Meals · 2025-03-28 | Kerendia | $20 |
| Amgen | Meals · 2025-03-21 | Tavneos | $27 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-03-14 | Farxiga | $23 |
| Amgen | Meals · 2025-03-07 | Krystexxa | $31 |
| Travere Therapeutics | Meals · 2025-02-28 | None | $36 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-26 | Farxiga | $104 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-02-14 | Farxiga | $23 |
| Fresenius USA Marketing | Meals · 2025-01-31 | Velphoro | $25 |
| NxStage Medical | Meals · 2025-01-22 | Nxstage System One | $131 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-01-17 | Lokelma | $16 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $5,593
| Fresenius USA Marketing | Velphoro | $4,622 | 10 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $498 | 15 payments
|
| Amgen | Aranesp | $138 | 3 payments
|
| Travere Therapeutics | None | $79 | 5 payments
|
| Calliditas Therapeutics US | Tarpeyo | $78 | 4 payments
|
| Bayer Healthcare Pharmaceuticals | Kerendia | $72 | 3 payments
|
| Ardelyx | Ibsrela | $51 | 2 payments
|
| Vifor Pharma | Veltassa | $21 | 1 payment
|
| Lilly USA | Jardiance | $18 | 1 payment
|
| Novo Nordisk | None | $16 | 1 payment
|
2023: $3,003
| Bayer Healthcare Pharmaceuticals | Kerendia | $2,312 | 5 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $163 | 9 payments
|
| Fresenius USA Marketing | Velphoro | $157 | 7 payments
|
| Amgen | Tavneos | $147 | 2 payments
|
| Travere Therapeutics | None | $76 | 4 payments
|
| Vifor Pharma | Veltassa | $46 | 2 payments
|
| Horizon Therapeutics plc | Krystexxa | $44 | 2 payments
|
| Calliditas Therapeutics US | Tarpeyo | $33 | 1 payment
|
| Lilly USA | Mounjaro | $24 | 1 payment
|
2022: $1,208
| Vifor Pharma | Veltassa | $375 | 17 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $329 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $250 | 7 payments
|
| Fresenius USA Marketing | Velphoro | $207 | 10 payments
|
| Horizon Therapeutics plc | Krystexxa | $25 | 1 payment
|
| Aurinia Pharma U.S. | Lupkynis | $22 | 1 payment
|
2021: $318
| Fresenius USA Marketing | Velphoro | $177 | 12 payments
|
| Vifor Pharma | Veltassa | $123 | 6 payments
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $19 | 1 payment
|
2020: $107
| Bard Peripheral Vascular | None | $107 | 1 payment
|
2019: $728
| Relypsa | Veltassa | $359 | 55 payments
|
| Otsuka America Pharmaceutical | Jynarque | $216 | 2 payments
|
| Akebia Therapeutics | Auryxia | $130 | 1 payment
|
| Hikma Pharmaceuticals USA | Mitigare | $23 | 1 payment
|
Professional record
- NPI
- 1962502872
- Licence
- CA A37526California A37526: Cancelled
- Trained
- Wake Forest University School of Medicine, 1999 · 27 years ago
- Group
- San Mateo Dialysis Associates · County of San Mateo
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- HI 522236-01
- Taxonomy
- Federal specialty code 207RN0300X (207RN0300X)
- Mailing address
- 1301 Shoreway Rd, Suite 100, Belmont, CA, 94002
- NPI first listed
- 2006-09-22
- NPI last updated
- 2008-05-16
This is when the NPI record was last certified, not a medical board exam.